Literature DB >> 30496440

Reply to Giménez et al.

Lynn El Haddad1, Ella Ariza-Heredia1, Roy F Chemaly1.   

Abstract

Mesh：

Year:  2019        PMID： 30496440      PMCID： PMC6467185          DOI： 10.1093/infdis/jiy687

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

1.  Enumeration of cytomegalovirus-specific interferongamma CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection.

Authors:  Carlos Solano; Isana Benet; María A Clari; José Nieto; Rafael de la Cámara; Javier López; Juan C Hernández-Boluda; María J Remigia; Isidro Jarque; María L Calabuig; Ana Garcia-Noblejas; Juan Alberola; Amparo Tamarit; Concepción Gimeno; David Navarro
Journal:  Haematologica       Date:  2008-07-04       Impact factor: 9.941

2.  The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients.

Authors:  Lynn El Haddad; Ella Ariza-Heredia; Dimpy P Shah; Ying Jiang; Ted Blanchard; Shashank S Ghantoji; Firas El Chaer; Danielle El-Haddad; Amrita Prayag; Lior Nesher; Katy Rezvani; Elizabeth Shpall; Roy F Chemaly
Journal:  J Infect Dis       Date:  2019-02-23       Impact factor: 5.226

3.  An Interventional Study Using Cell-Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation.

Authors:  D Kumar; M Mian; L Singer; A Humar
Journal:  Am J Transplant       Date:  2017-06-16       Impact factor: 8.086

4.  General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation.

Authors:  Rima M Saliba; Katayoun Rezvani; Ann Leen; Jeffrey Jorgensen; Nina Shah; Chitra Hosing; Simrit Parmar; Betul Oran; Amanda Olson; Gabriela Rondon; Julianne Chen; Charles Martinez; Amir Hamdi; Rohtesh S Mehta; Roy F Chemaly; Ila M Saunders; Catherine M Bollard; Elizabeth J Shpall
Journal:  Biol Blood Marrow Transplant       Date:  2015-02-20       Impact factor: 5.742

5.  Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients.

Authors:  Lior Nesher; Dimpy P Shah; Ella J Ariza-Heredia; Jacques M Azzi; Hala K Siddiqui; Shasank S Ghantoji; Lisa Y Marsh; Lamprinos Michailidis; George Makedonas; Katy Rezvani; Elizabeth J Shpall; Roy F Chemaly
Journal:  J Infect Dis       Date:  2016-02-11       Impact factor: 5.226

6.  Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.

Authors:  Dominika Deborska-Materkowska; Agnieszka Perkowska-Ptasinska; Anna Sadowska; Jolanta Gozdowska; Michał Ciszek; Marta Serwanska-Swietek; Piotr Domagala; Dorota Miszewska-Szyszkowska; Elzbieta Sitarek; Agnieszka Jozwik; Artur Kwiatkowski; Magdalena Durlik
Journal:  BMC Infect Dis       Date:  2018-04-16       Impact factor: 3.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.